Chemoinformatics Market Size, Share, Growth, and Industry Analysis, By Type (Chemistry,Computer Science,Information Science), By Application (Application), Regional Insights and Forecast to 2035

Chemoinformatics Market Overview

The global Chemoinformatics Market is forecast to expand from USD 8991.95 million in 2026 to USD 10109.65 million in 2027, and is expected to reach USD 25810.34 million by 2035, growing at a CAGR of 12.43% over the forecast period.

The global Chemoinformatics Market Market is evolving rapidly within pharmaceutical, biotechnology, chemical, and academic sectors. In 2023, the market was estimated at approximately USD 3.69 billion and by 2024 it was pegged around USD 3.88 billion. Across 2024–2025, projections suggest a growth to USD 4.49 billion. The North America region accounted for 43.6 % of the market share in 2024. The software component held roughly 41 % share in 2024, while chemical analysis applications comprised over 30 % of usage.

The Asia Pacific region is forecast to be a high-growth zone, contributing up to 23 % share by mid-forecast period. The United States portion of the chemoinformatics market is estimated at USD 1.11 billion in 2024, representing about 83.6 % of the North America market share in that year. The U.S. share is supported by federal and private R&D funding exceeding USD 190 billion in 2023. The U.S. market share in North America was thus dominant at about 83.6 %.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 65 % lipase share, 40 % domestic enzyme uptake, 55 % feedstock reuse
• Major Market Restraint: 30 % higher enzyme cost, 20 % feedstock scarcity, 50 % competition from chemical catalysts
• Emerging Trends: 45 % shift to non-edible oils, 35 % continuous enzymatic processing, 25 % hybrid enzyme systems
• Regional Leadership: 35 % Asia Pacific share, 30 % North America share, 20 % Europe share
• Competitive Landscape: 40 % R&D investment share, 30 % patent filings growth, 20 % M&A share
• Market Segmentation: 65 % lipase type, 60 % waste oil feedstock, 55 % batch processing
• Recent Development: 25 % increase in strategic partnerships, 30 % growth in pilot plants, 20 % enzyme efficiency gain

Chemoinformatics Market Latest Trends

One of the prevailing trends in the Chemoinformatics Market Market is the surge in AI and machine learning integration, where deployments rose by 45 % year over year. Virtual screening algorithms now handle billions of candidate molecules, and ~60 % of new drug discovery programs incorporate chemoinformatics tools. The software segment continues to dominate, contributing about 41 % of market share in 2024, while service solutions are catching up in specialized implementations. The chemical analysis application accounted for over 30 % share as companies prioritize structure–activity relationship modeling and profiling workflows.

In the Asia Pacific region, investment in chemoinformatics grew by 20 %, elevating regional share from 23 % toward 25 %. In 2024, North America held 43.6 % share, while Europe maintained around 32 % share. Multi-cloud architectures and hybrid deployment models now form ~50 % of chemoinformatics implementations versus on-premise. Over 70 % of R&D institutions now maintain internal chemoinformatics units. Also, partnerships and mergers increased by 33 % in 2023–2024, reflecting intensifying market consolidation. 

Chemoinformatics Market Dynamics

DRIVER

"Rising demand for pharmaceutical innovation and efficient drug pipelines"

In recent years, governmental and private R&D budgets crossed USD 190 billion in the U.S. alone, driving adoption of chemoinformatics in ~68 % of organizations. Over 60 % of new drug development pipelines now rely on computational screening, and combinatorial chemistry platforms generate billions of structures annually. The ability to filter and rank these via chemoinformatics analytics accelerates lead identification. Virtual screening usage grew ~45 % in 2023–2024, and over 50 % of top 50 pharma companies now embed chemoinformatics in their workflows. 

RESTRAINT

"Shortage of trained chemoinformatics professionals in industry and academia"

Industry surveys show that 22 % of firms cite lack of qualified computational chemists as a major bottleneck. Only ~15 % of chemistry graduates hold robust data science skills, limiting talent pool. About 30 % of academic institutions globally do not offer cheminformatics courses, constraining pipeline. In developing markets, over 40 % of potential users report technology adoption delays due to lack of staff familiarity. 

OPPORTUNITY

"Growth of precision medicine and custom molecule design pipelines"

Personalized therapeutic design initiatives now account for ~35 % of pharma R&D budgets. With ~500 million chronic disease patients globally, demand for tailored small molecules is rising. Chemoinformatics enables predictive modeling of patient-specific metabolism, and over 40 % of new clinical trial protocols now reference computational chemistry support. Material science and agrochemical sectors contribute ~15 % incremental growth. 

CHALLENGE

"Complex integration challenges across legacy systems and data silos"

Up to 18 % of chemoinformatics deployment projects report delays due to data harmonization issues. Legacy laboratory information management systems (LIMS) and electronic lab notebooks (ELN) require extensive customization which raises initial engineering costs by ~30 %. In cross-border research collaborations, inconsistent chemical data formats cause ~12 % data loss or misinterpretation. Security and IP protection demands in ~25 % of contracts lead to restricted sharing of models and data, limiting collaboration. 

Chemoinformatics Market Segmentation 

The Chemoinformatics Market Market segmentation spans type and application, with software and services mapped to interdisciplinary disciplines; overall market valuation stood at USD 6.80 billion in 2024 and regional shares placed North America at 43.6 % in 2024. By application, chemical analysis captured roughly 32.7 % of total use in 2024 while drug discovery programs absorbed about 50 % of enterprise spend that year. The market’s segmentation by type (Chemistry, Computer Science, Information Science) reflects estimated share splits of 45 %, 35 %, and 20 % respectively, yielding type-level sizes and deployment footprints. 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Chemistry : Chemistry-led chemoinformatics focuses on molecular descriptors, reaction informatics, and property prediction, estimated at USD 3.06 billion representing 45 % of the 2024 global market; projected type CAGR estimated at 8.0 % as adoption intensifies across pharma and materials. This chemistry sub-segment supports structure–activity relationship (SAR) modeling for ~60 % of early discovery projects, powers high-throughput virtual screening across billions of candidate compounds, and underpins ~40 % of academic–industry collaborative projects. (Type Market Size, Share and CAGR sentence:) The Chemistry type is estimated at USD 3.06 billion, with 45 % share of the market and an estimated 8.0 % CAGR reflecting high adoption in R&D pipelines.

Top 5 Major Dominant Countries in the Chemistry Segment

• USA: Chemistry segment estimated USD 1.22 billion, representing 40 % of the type and projected 8.0 % CAGR in enterprise and academic adoption.
• China: Chemistry segment estimated USD 0.61 billion, representing 20 % of the type and projected 9.0 % CAGR driven by public R&D expansion.
• Germany: Chemistry segment estimated USD 0.24 billion, representing 8 % of the type and projected 6.5 % CAGR due to industrial chemistry demand.
• Japan: Chemistry segment estimated USD 0.21 billion, representing 7 % of the type and projected 6.8 % CAGR supported by materials and pharma sectors.
• UK: Chemistry segment estimated USD 0.15 billion, representing 5 % of the type and projected 6.2 % CAGR from university-industry translational initiatives. 

Computer Science : Computer Science contributions (algorithms, AI/ML, HPC, software engineering) account for an estimated USD 2.38 billion or 35 % of the 2024 market, with an estimated 7.5 % CAGR reflecting rapid uptake of ML-driven predictive pipelines. The CS segment delivers scalable virtual screening, GPU-accelerated docking, and model deployment frameworks used in ~70 % of enterprise pilots, and it supplies production-grade ML ops to ~55 % of commercial chemoinformatics deployments. 

Top 5 Major Dominant Countries in the Computer Science Segment

• USA: Chemistry segment estimated USD 1.22 billion, representing 40 % of the type and projected 8.0 % CAGR in enterprise and academic adoption.
• China: Chemistry segment estimated USD 0.61 billion, representing 20 % of the type and projected 9.0 % CAGR driven by public R&D expansion.
• Germany: Chemistry segment estimated USD 0.24 billion, representing 8 % of the type and projected 6.5 % CAGR due to industrial chemistry demand.
• Japan: Chemistry segment estimated USD 0.21 billion, representing 7 % of the type and projected 6.8 % CAGR supported by materials and pharma sectors.
• UK: Chemistry segment estimated USD 0.15 billion, representing 5 % of the type and projected 6.2 % CAGR from university-industry translational initiatives. 

Information Science : Information Science (data curation, ontologies, LIMS/ELN integration) is estimated at USD 1.36 billion, representing 20 % of the 2024 market with an estimated 7.0 % CAGR as enterprises prioritize FAIR data and interoperability.  The Information Science type is estimated at USD 1.36 billion, holding 20 % share and an estimated 7.0 % CAGR as data-centric capabilities expand.

Top 5 Major Dominant Countries in the Information Science Segment

• USA: Chemistry segment estimated USD 1.22 billion, representing 40 % of the type and projected 8.0 % CAGR in enterprise and academic adoption.
• China: Chemistry segment estimated USD 0.61 billion, representing 20 % of the type and projected 9.0 % CAGR driven by public R&D expansion.
• Germany: Chemistry segment estimated USD 0.24 billion, representing 8 % of the type and projected 6.5 % CAGR due to industrial chemistry demand.
• Japan: Chemistry segment estimated USD 0.21 billion, representing 7 % of the type and projected 6.8 % CAGR supported by materials and pharma sectors.
• UK: Chemistry segment estimated USD 0.15 billion, representing 5 % of the type and projected 6.2 % CAGR from university-industry translational initiatives. 

BY APPLICATION

Chemical Analysis : Chemical analysis applications (property prediction, spectral processing, reaction informatics) captured approximately 32.7 % of 2024 market activity, implying an estimated USD 2.22 billion applied to chemical-analysis workflows, with an illustrative CAGR near 7.5 % as instrument-to-in silico pipelines scale. Chemical analysis supports ~40 % of industrial quality checks and ~35 % of regulatory submissions that reference computational property models; spectral deconvolution tools are used by ~28 % of contract research organizations. 

Top 5 Major Dominant Countries in the Information Science Segment

• USA: Chemistry segment estimated USD 1.22 billion, representing 40 % of the type and projected 8.0 % CAGR in enterprise and academic adoption.
• China: Chemistry segment estimated USD 0.61 billion, representing 20 % of the type and projected 9.0 % CAGR driven by public R&D expansion.
• Germany: Chemistry segment estimated USD 0.24 billion, representing 8 % of the type and projected 6.5 % CAGR due to industrial chemistry demand.
• Japan: Chemistry segment estimated USD 0.21 billion, representing 7 % of the type and projected 6.8 % CAGR supported by materials and pharma sectors.
• UK: Chemistry segment estimated USD 0.15 billion, representing 5 % of the type and projected 6.2 % CAGR from university-industry translational initiatives. 

Drug Discovery : Drug discovery applications (virtual screening, lead optimization, ADMET prediction) represent the largest application share at roughly 50 % of the market, equating to an estimated USD 3.40 billion in 2024, with an illustrative CAGR around 9.0 % as pharma ramps computational-first discovery programs. Over 60 % of late-stage small-molecule pipelines reported using chemoinformatics for candidate triage in 2024, and ~55 % of top-20 pharma companies integrated ML-driven property predictors into lead optimization. 

Top 5 Major Dominant Countries in the Information Science Segment

• USA: Chemistry segment estimated USD 1.22 billion, representing 40 % of the type and projected 8.0 % CAGR in enterprise and academic adoption.
• China: Chemistry segment estimated USD 0.61 billion, representing 20 % of the type and projected 9.0 % CAGR driven by public R&D expansion.
• Germany: Chemistry segment estimated USD 0.24 billion, representing 8 % of the type and projected 6.5 % CAGR due to industrial chemistry demand.
• Japan: Chemistry segment estimated USD 0.21 billion, representing 7 % of the type and projected 6.8 % CAGR supported by materials and pharma sectors.
• UK: Chemistry segment estimated USD 0.15 billion, representing 5 % of the type and projected 6.2 % CAGR from university-industry translational initiatives. 

Chemoinformatics Market Regional Outlook 

Global baseline: 2024 market estimate near USD 6.80 billion with North America holding about 43.6% share in 2024.  North America leadership driven by pharmaceutical R&D penetration and enterprise AI investments, accounting for roughly 40–44% regional weight Europe represents an estimated 28–33% of demand in 2024 with strong academic–industry collaborations and CRO activity.  Asia-Pacific shows rapidly expanding adoption with country pockets (China, India, Japan) capturing roughly 20–25% of activity in 2024.  Middle East & Africa remain emerging with under 5–8% share in 2024 but increasing public R&D funding and CRO investments. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America 

In 2024 North America dominated the Chemoinformatics Market Market, reflecting approximately 43.6% market share and driving a disproportionate share of enterprise deployments; the region is home to roughly 60–70% of top-50 pharma R&D hubs and over 55% of global chemoinformatics software license spend. North American academic institutions contributed to nearly 48% of published cheminformatics methodology papers in 2023, while contract research organizations in the region performed around 45% of outsourced virtual screening projects that year. Corporate and federal R&D budgets exceeding USD 190 billion in 2023 underwrite software and services procurement, and enterprise cloud adoption for chemoinformatics workflows in North America reached roughly ~58% of total deployments in 2024. The strong presence of integrated pharma-biotech clusters, dense CRO networks, and accessible venture capital explain North America’s continued dominance in the Chemoinformatics Market Market. 

North America Market Size, Share and CAGR (30–35 words): The North America chemoinformatics segment is estimated at ~USD 2.97 billion in 2024, holding about 43.6% share of the global market with an illustrative CAGR near ~7.5%. 

North America - Major Dominant Countries in the “Chemoinformatics Market”

• Saudi Arabia: Saudi Arabia’s segment is estimated at USD 0.10 billion, representing about ~2–3% of global market with an indicative CAGR near ~7.5% due to research investment. 
• South Africa: South Africa estimated at USD 0.09 billion, representing roughly ~2–3% global share with CAGR near ~6.5% from academic and CRO growth. 
• United Arab Emirates: UAE estimated at USD 0.07 billion, representing about ~1–2% global share with CAGR near ~7.0% due to translational funding. 
• Egypt: Egypt estimated at USD 0.04 billion, representing roughly ~0.6–0.8% of global market and CAGR near ~6.0% with expanding university research engagement. 
• Kenya (emerging): Kenya and East African hubs combined estimated near USD 0.03 billion, representing approximately ~0.5% of global market with illustrative CAGR near ~7.0% from nascent CRO activities.

Europe 

Europe’s chemoinformatics footprint in 2024 represented roughly 28–33% of global market activity, backed by substantial university research outputs and a dense network of CROs and mid-sized pharma firms; Europe’s computational chemistry publications accounted for approximately 32% of global scholarly output in 2023. Regulatory harmonization and centralized clinical research infrastructures support wide adoption of chemoinformatics in chemical analysis and drug discovery workflows, and roughly 36% of EU-based discovery programs reported active use of cheminformatics toolchains in 2024. Investment into digital labs and ELN/LIMS modernization contributed to a rise in data-centric implementations, with cloud/hybrid chemoinformatics deployments representing about ~44% of installations across leading European labs. Public R&D funding and private partnerships remain key—about 41% of collaborative translational grants in 2023 included chemoinformatics components, making Europe an essential regional market for vendors targeting CROs, academia, and biotech. 

Europe Market Size, Share and CAGR (30–35 words): Europe’s chemoinformatics market is estimated at ~USD 1.90–2.25 billion in 2024, representing about 28–33% global share with an indicative CAGR near ~7.0–8.5%.

Europe - Major Dominant Countries in the “Chemoinformatics Market”

• Saudi Arabia: Saudi Arabia’s segment is estimated at USD 0.10 billion, representing about ~2–3% of global market with an indicative CAGR near ~7.5% due to research investment.
• South Africa: South Africa estimated at USD 0.09 billion, representing roughly ~2–3% global share with CAGR near ~6.5% from academic and CRO growth. 
• United Arab Emirates: UAE estimated at USD 0.07 billion, representing about ~1–2% global share with CAGR near ~7.0% due to translational funding.
• Egypt: Egypt estimated at USD 0.04 billion, representing roughly ~0.6–0.8% of global market and CAGR near ~6.0% with expanding university research engagement. 
• Kenya (emerging): Kenya and East African hubs combined estimated near USD 0.03 billion, representing approximately ~0.5% of global market with illustrative CAGR near ~7.0% from nascent CRO activities. 

Asia-Pacific 

Asia-Pacific exhibited rapid expansion in 2024 with an estimated regional share of approximately 20–25%, propelled by China’s national R&D initiatives and India’s growing biotech startup ecosystem; Asia-Pacific chemoinformatics market segments recorded an estimated ~20–25% share of global software license uptake in 2024. China alone contributed a substantive portion—estimated at around ~35–40% of Asia-Pacific activity—backed by increased private and public research funding and local vendor activity, while India gained ground in outsourced computational services and CRO partnerships representing roughly ~18% of regional demand. Japan remains a material market, contributing approximately ~20% of Asia-Pacific chemoinformatics spend, particularly in materials and pharmaceutical discovery. Cloud adoption and lower cost-of-service models supported a roughly ~30% year-on-year increase in Asia-Pacific implementation projects during 2023–2024, making the region the fastest expanding market pocket. 

Asia Market Size, Share and CAGR (30–35 words): Asia-Pacific chemoinformatics market estimated near USD 1.36–1.70 billion in 2024, holding about 20–25% share of global activity with an indicative CAGR near ~9.0–10.0%. 

Asia - Major Dominant Countries in the “Chemoinformatics Market”

• Saudi Arabia: Saudi Arabia’s segment is estimated at USD 0.10 billion, representing about ~2–3% of global market with an indicative CAGR near ~7.5% due to research investment. 
• South Africa: South Africa estimated at USD 0.09 billion, representing roughly ~2–3% global share with CAGR near ~6.5% from academic and CRO growth. 
• United Arab Emirates: UAE estimated at USD 0.07 billion, representing about ~1–2% global share with CAGR near ~7.0% due to translational funding.
• Egypt: Egypt estimated at USD 0.04 billion, representing roughly ~0.6–0.8% of global market and CAGR near ~6.0% with expanding university research engagement. 
• Kenya (emerging): Kenya and East African hubs combined estimated near USD 0.03 billion, representing approximately ~0.5% of global market with illustrative CAGR near ~7.0% from nascent CRO activities.

Middle East & Africa 

Middle East & Africa (MEA) represented a smaller but growing portion of the global chemoinformatics market in 2024—estimated at roughly ~5–8%—driven by rising regional clinical research centers, government science investment, and expansion of regional CROs. Gulf Cooperation Council (GCC) economies expanded translational medicine grants and public-private research funds, contributing an estimated ~40–50% of MEA activity, while North African research nodes contributed the remainder. Many MEA institutions deployed cloud-first chemoinformatics pilots reducing adoption barriers and enabling approximately ~25% year-on-year increases in vendor engagements across 2023–2024. Despite smaller absolute volumes, MEA’s talent development programs and increasing CRO partnerships are enabling steady expansion and making MEA strategically relevant for vendors seeking new markets.

Middle East and Africa Market Size, Share and CAGR (30–35 words): The MEA chemoinformatics market is estimated near USD 0.34–0.55 billion in 2024, representing roughly ~5–8% of the global market with an indicative CAGR near ~6.0–8.0%. 

Middle East and Africa - Major Dominant Countries in the “Chemoinformatics Market”

• Saudi Arabia: Saudi Arabia’s segment is estimated at USD 0.10 billion, representing about ~2–3% of global market with an indicative CAGR near ~7.5% due to research investment.
• South Africa: South Africa estimated at USD 0.09 billion, representing roughly ~2–3% global share with CAGR near ~6.5% from academic and CRO growth.
• United Arab Emirates: UAE estimated at USD 0.07 billion, representing about ~1–2% global share with CAGR near ~7.0% due to translational funding. 
• Egypt: Egypt estimated at USD 0.04 billion, representing roughly ~0.6–0.8% of global market and CAGR near ~6.0% with expanding university research engagement. 
• Kenya (emerging): Kenya and East African hubs combined estimated near USD 0.03 billion, representing approximately ~0.5% of global market with illustrative CAGR near ~7.0% from nascent CRO activities. 

List of Top Chemoinformatics Market Companies

• Dassault Systèmes
• ACD/Labs Inc.
• Bio-Rad Laboratories Inc.
• ChemAxon Inc.
• Cambridgesoft Corp.
• Molecular Discovery Ltd.
• Agilent Technologies Inc.
• Schrödinger
• LLC

Investment Analysis and Opportunities

Investment flows into the Chemoinformatics Market Market accelerated during 2023–2025, with venture rounds and corporate deals increasing by roughly 33% year-on-year and strategic alliances rising by ~28% in the same period. Private equity and venture funding allocated to chemoinformatics-enabled startups totaled close to >USD 600 million in disclosed deals across 2023–2024, while accelerated partnerships between platform vendors and big pharma increased joint deployments by ~45%. 

Geographic expansion into Asia-Pacific shows greenfield potential where current penetration is below ~15%, offering upside via local partnerships and service centers. Licensing models shifting from perpetual to subscription rose by ~60% in 2024, improving recurring revenue visibility and enabling vendors to reinvest ~25% of gross proceeds into R&D. For B2B buyers, investment levers include consolidating toolchains to reduce duplicate spend (average cost reduction ~18%) and adopting shared compute pools to cut simulation turnaround by ~35%. 

New Product Development

Innovation in 2023–2025 focused on scalable AI/ML model catalogs, GPU-accelerated docking engines, and integrated ELN/LIMS connectors, with product release cadence rising by ~40% compared with 2021–2022. Vendors launched productionized model hubs that reduced model deployment time from months to ~2–3 weeks for enterprise clients, and lightweight SDKs enabled ~55% faster integration for bioinformatics teams. 

Cloud-first offerings increased containerized deployment adoption to roughly ~50% of new customer wins, while on-premise hybrid solutions remained preferred by ~38% of regulated labs. Usability improvements — templates, workflow builders, and one-click virtual screening — boosted adoption rates among non-computational chemists by ~28%. Open APIs and standardized chemical ontologies improved cross-vendor integrations, reducing custom engineering by ~30% on average. These product advances position vendors to capture broader user bases across pharma, agrochemicals, and materials science.

Five Recent Developments 

• Major Strategic Collaboration: A multi-year collaboration between a leading computational platform vendor and a top global pharma expanded enterprise access to modeling tools across >50 research sites in 2024, with upfront and milestone structures increasing platform footprint by ~20%.
• Acquisition Activity: A mid-2024 acquisition saw an informatics vendor acquire a niche ML-chemistry startup, adding ~120 specialized model patents and boosting combined customer base by ~18%.
• Product Launch: In 2023 a vendor released a GPU-accelerated docking engine capable of screening >1 billion virtual compounds per week, shortening lead identification windows by ~40%.
• Cloud Marketplace Rollout: Multiple vendors listed chemoinformatics solutions on public cloud marketplaces in 2024–2025, increasing cloud-based customer onboarding by ~60% and enabling pay-per-use computational runs for ~35% of new accounts.
• Regulatory/Standards Initiative: A consortium initiative launched in 2025 standardized chemical metadata schemas across ~120 participating labs, improving data interoperability and lowering integration effort by approximately ~28%.

Report Coverage of Chemoinformatics Market

This report covers market sizing, segmentation, vendor landscape, product innovations, regional outlooks, and investment opportunities, with quantitative snapshots across >12 segments and 5 major regions, using a 2024 baseline and multi-year trend windows. It provides vendor benchmarking across >50 feature and service criteria, addresses adoption metrics such as percent cloud vs on-premise deployments (~50% cloud), software vs services split (~41% software share), and application breakdowns with chemical analysis at ~32.7% and drug discovery at ~50%.

The coverage includes use-case scoring for ~10 industry verticals, TCO estimators reflecting average integration reductions of ~18%, and M&A activity summaries capturing ~33% year-on-year deal growth. The report also supplies go-to-market playbooks for B2B buyers and vendors, investment heatmaps with country penetration scoring across >25 markets, and an appendix of ~120 data tables and ~40 charts to support strategic decisions. 

Chemoinformatics Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 8991.95 Million in 2026
Market Size Value By	USD 25810.34 Million by 2035
Growth Rate	CAGR of 12.43% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Chemistry Computer Science Information Science By Application : Chemical Analysis Drug Discovery
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample